Chemical industry – Page 93

Business
5000 jobs to be cut at Teva

2013-10-14T00:00:00Z

Generics giant aims to cut costs and reinvest in R&D
Business
Solvay expands surfactants business with Chemlogics buyout

2013-10-09T00:00:00Z

$1.3bn deal brings firm into booming US oil and gas drilling market
Business
GSK to apply for malaria vaccine approval

2013-10-09T00:00:00Z

Infection protection drops over time, but the firm will go ahead with regulatory submission
Business
Lundbeck cuts jobs in Europe, but expands in US

2013-10-04T00:00:00Z

Depression drug approval fuels US recruitment
Business
Amid huge cuts, Merck vows research focus

2013-10-04T00:00:00Z

8500 more jobs to be axed, but the drugmaker ‘remains committed to innovation’
Business
Aspen acquires anticoagulant brands

2013-10-02T00:00:00Z

South African drugmaker buys thrombosis drugs from GSK for £700m
Business
Malvern sizes up Nanosight fit

2013-10-01T00:00:00Z

Nanoparticle characterisation firm bought for £15 million
Business
Japan confirms Novartis clinical trial data fabrication

2013-10-01T00:00:00Z

Investigation into blood pressure blockbuster continues
Business
Clariant expands into China

2013-09-30T00:00:00Z

Firm buys pigments arm of Jiangsu Multicolor and will build new plant
Business
Algal oil producer steps up supply

2013-09-27T00:00:00Z

Solazyme to provide 10,000 tonnes of tailored oil to Unilever
Business
Norway abandons full-scale CCS project

2013-09-27T00:00:00Z

Technology development centre will receive extra funding
Business
New respiratory drugs neck and neck

2013-09-25T00:00:00Z

Combination inhalers from GSK and Novartis approved in EU and Japan
Business
Nanobody inflammation drug attracts Abbvie

2013-09-25T00:00:00Z

$840m licensing deal shows support for antibody fragments
Careers
Non-profit pharma

2013-09-24T00:00:00Z

Not-for-profit drug discovery is growing into a promising niche employment opportunity within the pharmaceutical industry. James Mitchell Crow investigates
Business
Service with a smile

2013-09-18T00:00:00Z

Company profile: Charnwood Molecular is more than a run-of-the-mill contract synthesis provider
Business
GSK criticised for trial data secrecy

2013-09-17T00:00:00Z

Italian research institute abandons collaboration over data access
Business
UK objects to pesticide ban in gardens

2013-09-16T00:00:00Z

Government disagrees with EU neonicotinoid moratorium, but will implement it
Business
First biosimilar antibody drugs approved in Europe

2013-09-11T00:00:00Z

European commission gives final approval to generic infliximab copies
Business
GSK divests Lucozade and Ribena brands

2013-09-10T00:00:00Z

£1.35 billion deal allows GSK to focus on pharma business
Business
Otsuka to buy Astex for $886 million

2013-09-06T00:00:00Z

Japanese firm intends to leave Astex’s fragment-based R&D efforts intact